Program
Symposium on Molecular and Physiological Aspects of Diabetes Mellitus
November 13, 2015
9:00 – 9:10 Welcome Note
Juleen Zierath
9:10 – 9:20 The 4D Type 2 diabetes project: Standardized care process, a platform for
excellent care and research
Eva Toft, Ersta Hospital
9:20 – 9:55 The Kidney in Diabetes
Sally Marshall, Institute of Cellular Medicine, Newcastle University, UK
9:55 – 10:30 The diabetes epidemic: fact and fiction
Sarah Wild, Centre for Population Health Sciences, University of Edinburgh, UK
10:30 – 11:00 COFFEE BREAK
11:00 – 11:35 Genes and Metabolism: What lessons have we learned so far?
Inês Barroso, Wellcome Trust Sanger Institute, Hinxton, UK
11:35-12:10 Insulin resistance in cardiovascular disease development
Markku Laakso, Dept. of Medicine, University of Kuopio, Finland
12:10-13:10 LUNCH
13:10- 13:45 Metabolic dysregulation and insulin action: human phenotypic considerations
William T. Cefalu, Pennington Biomedical Research Center, New Orleans, USA
13:45-14:20 Obesity-related Insulin Resistance: A Systems Approach
Daniel P. Kelly, Sanford Burnham Prebys Medical Discovery Institute at Lake
Nona, Orlando, USA
14:20-14:50 COFFEE BREAK
14:50-15:25 Taking care of the gut microbiota to control diabetes and related metabolic
diseases
Nathalie Delzenne, Metabolism and Nutrition Research Group, Catholic
University of Louvain, Louvain Drug Research Institute (LDRI), Belgium
15:25-16:00 Aging of the autophagic system: Metabolic consequences
Ana Maria Cuervo, Albert Einstein College of Medicine, New York, USA
CLOSING REMARKS
Integrative physiology/Karolinska Institutet
von Eulers väg 4a, IV/SE-171 77 Stockholm
Symposium on Molecular and
Physiological Aspects of Diabetes
Mellitus
13 November 2015
Karolinska Institutet, Solna 9.00–16.00
Attendance is free of charge and open for everyone,
however registration is mandatory at: ki.se/en/srp-diabetes
Photo: Science Pgoto Library
speakers:
Sally Marshall, Newcastle University, UK
Sarah Wild, University of Edinburgh, UK
Inês Barroso, Wellcome Trust Sanger Institute, UK
Markku Laakso, University of Kuopio, Finland
William T. Cefalu, Pennington Biomedical Research Center, USA
Daniel P. Kelly, Sanford Burnham Prebys Medical Discovery
Institute at Lake Nona, USA
Nathalie Delzenne, Catholic University of Louvain, Belgium
Ana Maria Cuervo, Albert Einstein College of Medicine, USA
KAROLINSKA INSTITUTET
CONFERENCES
2015
Arranged by the Strategic Research Programme in Diabetes
Registration
required latest
1 November
